C9orf72 and frontotemporal dementia: The recent discovery of the hexanucleotide repeat expansion in the C9orf72 gene as the causative agent of c9FTD/ALS gives rise to the opportunity to develop new therapies directed at this mutation, which is responsible for a large proportion of FTD and/or ALS cases.